Management of severe COPD through a multidisciplinary approach
Official title: Longitudinal, Open Label, Clinical Trial Evaluating the Effectiveness of Detailed Phenotyping and Subsequent Multidisciplinary Management of Both COPD and Multimorbidity in Patients With COPD After a Hospitalization Due to Acute Exacerbation of COPD.
Run by Vastra Gotaland Region · NCT04860375 · Data updated 2026-11-12
This study is testing a team-based approach to care for people with severe COPD who have been hospitalized to see if it helps them feel better and have fewer flare-ups compared to regular treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 40 Years to 100 Years |
| Sex | All |
| Enrollment | 110 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Gothenburg, VGR) |
| Status | Recruiting |
| Started | September 22, 2021 |
| Main results expected | December 31, 2028 |
| Study ends | June 30, 2029 |
| Registry record updated | May 14, 2026 |
| Trial ID | NCT04860375 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 40 and older with a history of smoking and prior hospitalization due to COPD exacerbations.
✕Probably not a fit
Patients with alternative diagnoses for their respiratory symptoms or those unable to comply with study procedures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study focuses on the multidisciplinary management of patients with severe Chronic Obstructive Pulmonary Disease (COPD), particularly those experiencing exacerbations. It aims to provide comprehensive patient care that integrates various healthcare professionals to improve outcomes for individuals suffering from this debilitating condition. The study will involve patients who have been hospitalized due to worsening respiratory symptoms and will assess the effectiveness of this collaborative approach compared to standard care. The goal is to enhance the quality of life and reduce the frequency of exacerbations in COPD patients.
Why it matters
Potential benefit: If successful, this approach could significantly improve the management and quality of life for patients with severe COPD.
How similar studies have gone: Other studies have shown promising results with multidisciplinary approaches in managing chronic diseases, suggesting potential success for this method in COPD management.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Male or female patients, aged ≥40 years. 2. Smokers or ex-smokers (≥10 pack-year). 3. Prior hospitalization because of progressively worsening dyspnea (associated or not with increased cough and sputum, and or sputum purulence), with a clinically suspected diagnosis of exacerbations of COPD that prompt the discharging physician to refer the patient to the COPD Center. 4. Signed informed concent form. Exclusion Criteria: 1. Presenting to the hospital for similar symptoms, which are not defined by the clinicians as suspected exacerbations of COPD, because of alternative diagnoses not related to patients with COPD (e.g., chest wall trauma, neurological disorders, sepsis, cancer and anemia). 2. Already enrolled in other studies perceived to interfere with this protocol. 3. In whom spirometry test is contraindicated (e.g., hemoptysis, detached retina, active tuberculosis). 4. Unable to comply with study procedures and follow-ups in the opinion of the Investigator (e.g., other severe diseases with short life expectancy or who make it impossible for the patients to participate into the study, evidence of alcohol or drug abuse, dementia, severe psychiatric disorder). 5. Acute myocardial infarction and unstable angina pectoris or arrhythmias requiring specific cardiology ICU. 6. Diagnosed stroke, dementia, degenerative neurological disorders or psychiatry disorders requiring specialized care. 7. At the discretion of the recruiting clinician would not be able to be considered for the study.
Where it's running
-
COPD-Center
Gothenburg, Vgr, Sweden Recruiting
Study contacts
- Principal investigator: Lowie Vanfleteren — COPD-center, Sahlgrenska University Hospital
- Study coordinator: Lowie Vanfleteren
- Email: lowie.vanfleteren@vgregion.se
- Phone: 0046736601730
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Support for COPD patients after hospital discharge
This study tests whether giving COPD patients special rescue packs with medication and a management plan after they leave the hospital can help them stay healthier and avoid going back to the hospital.
-
Comparing new nasal interface with standard cannula for COPD patients
This study is testing a new type of nasal breathing device against a standard one to see which helps people with COPD feel better during a flare-up.
-
AERO-007: a inhaled LABA+LAMA combination for COPD through a nebulizer
This study tests whether a nebulized LABA+LAMA combination can improve lung function in adults with COPD.
-
Cognitive load and inhaler technique in COPD
This study tests whether adding a short memory task while using an inhaler makes COPD patients more likely to misuse their inhaler.
-
Balance training after pulmonary rehab for COPD to help steadiness and reduce falls
A COPD-focused balance training program called Sport4Steadiness is being tested to see if people with COPD will accept it and if the study processes work well.
-
Continuous vs High-Intensity Interval Exercise in COPD
This study tests whether continuous versus high-intensity interval exercise affects cerebral oxygenation in people with COPD.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.